Benign Paroxysmal Positional Vertigo Clinical Trial
Official title:
"Randomized, Controlled 3-arm Clinical Study to Evaluate the Efficacy of Supplementation With Vertistop® D and Vertistop® L in Preventing Recurrences of Highly Recurring BPPV (Benign Paroxysmal Positional Vertigo)".
The study involves the evaluation of 3 groups of subjects (3-arm study). Patients diagnosed with BPPV and "sufficient" serum concentrations of Vitamin D (>30 ng/mL, >75 nmol/L) at baseline may be treated with 2 tablets per day (morning and evening) of Vertistop® L ( Alpha-lipoic acid, carnosine, zinc and curcumin) or untreated, on the basis of the randomization criterion to which they will be assigned. Patients with Vitamin D "deficiency" (<20 ng/mL, <50 nmol/L) or Vitamin D "insufficient" (20-30 ng/mL, 50-75 nmol/L) at baseline, or subsequent follow-up, they will be treated for 2 months with Vertistop® D (alpha-lipoic acid, carnosine and zinc, vitamin D3 and vitamins of the B complex) taking 1 tablet a day (before meals). The main purpose of the study is to evaluate, over a period of 6 months, the efficacy of Vertistop® D and Vertistop® L supplementation in preventing recurrences of BPPV (Benign Paroxysmal Positional Vertigo), in relation to blood levels of Vitamin D.
Patients will be assigned to one of the three study groups following a randomization list with reference to groups 1 and 2 and according to the serum concentrations of 25(OH) Vitamin D, evaluated at the baseline visit, with reference to group 3. The determination of the Vitamin D concentration will be requested by the Investigating physician and the report will be evaluated during the randomisation visit (V1), Visit 2, (after 2 months from enrollment/start of treatment), Visit 3 (Follow-up visit up to 4 months from enrollment) and finally Visit 4 (Follow-up visit 6 months after enrollment). The blood sample and the Vitamin D dosage will be carried out the week before the day of the visit agreed with the Investigator, in a trusted laboratory of the patient, provided that it has the legal authorizations and the analytical methodology satisfactory the measurement intervals reported in Protocol. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03425786 -
Benign Paroxysmal Positional Vertigo (BPPV) Training for Sports Medicine Providers in a Pediatric Concussion Program
|
N/A | |
Completed |
NCT02046980 -
Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
|
Phase 2 | |
Withdrawn |
NCT00978809 -
Effects of Physical Treatment on Postural Stability in Benign Paroxysmal Positional Vertigo (BPPV) Patients
|
N/A | |
Completed |
NCT02029508 -
The Treatment of Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo
|
Phase 3 | |
Completed |
NCT02809599 -
Evidence Based Best Care Practice for Benign Paroxysmal Positional Vertigo
|
N/A | |
Completed |
NCT03230513 -
Comparison of Home-Based Exercise on the Posterior Canal Benign Paroxysmal Positional Vertigo Symptoms
|
N/A | |
Completed |
NCT03643354 -
Evaluation of the Prevalence of BPPV and Longterm Effects of Its Therapy Using the Rotundum Device in Retirement Homes
|
N/A | |
Completed |
NCT00641797 -
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
|
N/A | |
Recruiting |
NCT06001047 -
Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
|
N/A | |
Not yet recruiting |
NCT04578470 -
Benign Paroxysmal Positional Vertigo (BPPV) in Older Patients
|
Phase 2 | |
Not yet recruiting |
NCT04578262 -
Epley Manoeuvre in Participants With Multiple Sclerosis Diagnosed From Benign Paroxysmal Positional Vertigo
|
N/A | |
Active, not recruiting |
NCT06314581 -
Effect of a Multifaceted Educational Intervention on the Implementation of Evidence-based Practices for Benign Paroxysmal Positional Vertigo in an Emergency Department
|
||
Completed |
NCT04715282 -
The Epley Maneuver Versus Cawthorne-Cooksey Exercises in the Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
|
N/A | |
Terminated |
NCT03161470 -
Efficacy of a Mechanical Chair for Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
|
N/A | |
Completed |
NCT05425199 -
Habituation Exercises Versus Proprioceptive Training in Benign Paroxysmal Positional Vertigo
|
N/A | |
Recruiting |
NCT05922774 -
Cervical Vestibular Evoked Myogenic Potentials in Recurrent and Persistant Benign Paroxysmal Positional Vertigo
|
||
Recruiting |
NCT05013684 -
Benign Paroxysmal Positional Vertigo in Older Adults
|
N/A | |
Not yet recruiting |
NCT05863949 -
Clinical Trial of Vit D and Calcium for Recurrent BPPV
|
N/A | |
Suspended |
NCT04026516 -
CAVA: Dizziness Trial
|
N/A | |
Completed |
NCT05127694 -
Treatment In Acute Benign Paroxysmal Positional Vertigo
|
N/A |